Friday, June 11th, 2021 -- An estimated 4.8 million ER visits are attributed to traumatic brain injuries (TBIs). These injuries are often undiagnosed or misdiagnosed, which can pose short-term risks, long-term risks, or even result in death. To combat this serious issue, Abbott Laboratories partnered with the US Department of Defense to work on a plasma test that can diagnose mild TBIs. The company hopes this test will be used in conjunction with current methods of diagnosis,